Published May 22, 2023
Study Design and Structure TRIUMPH-1 is a randomized, double-blind, placebo-controlled Phase 3 trial
Lane 1: affinity purification of GST from bacterial cell lysate using commercial sorbent Glutathione-Sepharose Lane 2: affinity purification of GST from bacterial cell lysate using immunosorbent prepared from anti-GST (S-tag-02
Join us as we explore the intricate connection between metabolic innovation and gastrointestinal well-being
Nat Med 28(10):20832091 Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J et al (2023) Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
These drugs are also appetite suppressants and were prescribed for obesity until they were withdrawn owing to negative side effects [107]